AB-BIOTICS is a biotech company that focuses on the research and development of a vast generation of natural probiotic strains formulated not only to meet therapeutic needs but also to maintain human health.
Innovative and clinically tested solutions based on scientific excellence
Ready-to-market products meeting different therapeutic needs
Committed to research and product development
AB-BIOTICS was founded in 2004 as a spin-off of the Autonomous University of Barcelona (UAB) launched by Miquel Àngel Bonachera and Sergi Audivert, current executive directors. In 2019 the international chemical company Kaneka Corporation acquired AB-BIOTICS. Now both companies work together to further develop microbiome science.
Find AB-BIOTICS products in more than 80 markets worldwide
A close-knit team that makes efficient and advanced probiotic science a reality
Our commitment to excellence in research and innovation also involves a professional, experienced and dynamic specialist team
An open-minded team for the launch and co-development of new products
Highly experienced in regulatory and market access processes
AB-BIOTICS counts with a team of professionals who are highly qualified in a variety of fields, including biotechnology, biochemistry, pharmacy, genetics and microbiology, to name a few.